|
|
|
Volumn 34, Issue 5, 2002, Pages 367-368
|
|
Confusing brand names
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPRAZOLAM;
CEFOTAXIME;
CEFTRIAXONE;
CEFUROXIME;
CELECOXIB;
CETAPIN;
CLOMIN;
CLOMIP;
CLOMIPRAMINE;
COLAX;
COXID;
CYCLOOXYGENASE 2 INHIBITOR;
CYPROHEPTADINE;
DICYCLOVERINE PLUS PARACETAMOL;
DIURETIC AGENT;
DOSULEPIN;
DOXYCYCLINE;
ERACEF;
EVACEF;
FLUCONAZOLE;
FLUMED;
FLUMET;
FOLIC ACID;
GENERIC DRUG;
GLEZ;
GLICLAZIDE;
GLIPIZIDE;
GLZ;
INDAPAMIDE;
INDICONTIN;
IRON POLYMALTOSE;
LISINOPRIL;
METFORMIN;
NEOSAID;
NIMESULIDE;
ODACE;
OLACE;
OLANZAPINE;
ORAXIM;
ORAXIN;
PHENYLEPHRINE;
PICOSULFATE SODIUM;
PYRANTEL EMBONATE;
RANITIDINE;
RANITIN;
RIFAMPICIN;
RINITRIN;
SERTRALINE;
SETALIN;
SINOPIL;
SINOPRIL;
SPARFLOXACIN;
SPOXIN;
THEOPHYLLINE;
TRIFER;
UFER;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
WINCID;
WINCIP;
WORMIN;
WORNIL;
ZOLAX;
ASTHMA;
CLINICAL PRACTICE;
CONFUSION;
CONTROLLED RELEASE FORMULATION;
CONVALESCENCE;
DISEASE SEVERITY;
DRUG CAPSULE;
DRUG FORMULARY;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG NOMENCLATURE;
ESSENTIAL HYPERTENSION;
FOLLOW UP;
HUMAN;
INDIA;
LETTER;
NEGLIGENCE;
PATIENT CARE;
PHYSICIAN;
PRESCRIPTION;
PUBLICATION;
STROKE;
SUSPENSION;
SYRUP;
TABLET;
TREATMENT FAILURE;
UNITED STATES;
WRITING;
|
|
EID: 0036799060
PISSN: 02537613
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (2)
|
|
References (1)
|
